US FDA Hiring Strategy Shifts Focus From ‘Vacancies’ To ‘Net Gains’
As outside report urges increased planning and culture changes, FDA OTS Director Keller says recruitment will stop ‘order taking’ and move to ‘forecasting the hiring needs of each of the centers.’
You may also be interested in...
Until hiring is completed, the new Office of Therapeutic Products director must head an office and two divisions she supervises in addition to her actual duties.
CDER Director Cavazzoni is seeing ‘net gains’ in hiring, including in key areas like medical officers. The agency still has lagging areas of need, like statisticians and inspector/investigators.
Vacancy notice includes preferences for candidates with experience formulating generic drug policy and strategy, as well as in overall drug development, which is intended to make the search more efficient.